Open House Discount Agreements 2024 02

Deadline: 31 Mar 2026

Germany

Ref. No.: 10606611

EMD:Ref Document

Bid Value: Ref Document

69 Days Left

Open House Biologics Discount Agreements 2024 10 Pertuzumab Trastuzumab Drug Combination

Deadline: 31 Dec 2026

Germany

Ref. No.: 10579947

EMD:Ref Document

Bid Value: Ref Document

344 Days Left

Open House Biologics Discount Agreements 2024 13 Somatropin

Deadline: 31 Dec 2026

Germany

Ref. No.: 10549827

EMD:Ref Document

Bid Value: Ref Document

344 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredients Mentioned With The Possibility Of Conclusion Within The Framework Of The So Called Open House Procedure

Deadline: 31 Dec 2026

Germany

Ref. No.: 10531330

EMD:Ref Document

Bid Value: Ref Document

344 Days Left

Medicines Containing The Active Ingredient Rituximab In The Dosage Form Concentrate For Infusion Solution Atc L01Fa01

Deadline: 31 Oct 2026

Germany

Ref. No.: 10526727

EMD:Ref Document

Bid Value: Ref Document

283 Days Left

Medicines Containing The Active Ingredient Sevelamer Hydrochloride Atc V03Ae02

Deadline: 31 Oct 2026

Germany

Ref. No.: 10506658

EMD:Ref Document

Bid Value: Ref Document

283 Days Left

Medicines Containing The Active Ingredient Combination Brinzolamide And Timolol Atc S01Ed67

Deadline: 31 Oct 2026

Germany

Ref. No.: 10504883

EMD:Ref Document

Bid Value: Ref Document

283 Days Left

Medicines Containing The Active Ingredient Bimekizumab Atc L04Ac21

Deadline: 31 Oct 2026

Germany

Ref. No.: 10497747

EMD:Ref Document

Bid Value: Ref Document

283 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredients Mentioned With The Possibility Of Conclusion Within The Framework Of The So Called Open House Procedure

Deadline: 31 Dec 2026

Germany

Ref. No.: 10490755

EMD:Ref Document

Bid Value: Ref Document

344 Days Left

Medicines Containing The Active Ingredient Combination Formoterol And Beclometasone Atc R03Ak08 In The Strength 200 6 Micrograms

Deadline: 31 Oct 2026

Germany

Ref. No.: 10482605

EMD:Ref Document

Bid Value: Ref Document

283 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredients Mentioned With The Possibility Of Conclusion Within The Framework Of The So Called Open House Procedure

Deadline: 31 Dec 2026

Germany

Ref. No.: 10471265

EMD:Ref Document

Bid Value: Ref Document

344 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredients Mentioned With The Possibility Of Conclusion Within The Framework Of The So Called Open House Procedure

Deadline: 31 Dec 2026

Germany

Ref. No.: 10438499

EMD:Ref Document

Bid Value: Ref Document

344 Days Left

Pharmaceutical Discount Agreements From 01 01 2025 For Various Active Ingredients Within The Framework Of An Open House Procedure

Deadline: 02 Nov 2026

Germany

Ref. No.: 10421797

EMD:Ref Document

Bid Value: Ref Document

285 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredients Mentioned With The Possibility Of Conclusion Within The Framework Of The So Called Open House Procedure

Deadline: 31 Dec 2026

Germany

Ref. No.: 10402001

EMD:Ref Document

Bid Value: Ref Document

344 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredients Mentioned With The Possibility Of Conclusion Within The Framework Of The So Called Open House Procedure

Deadline: 31 Dec 2026

Germany

Ref. No.: 10339271

EMD:Ref Document

Bid Value: Ref Document

344 Days Left

Discover Tenders by Uniforms Sector

Filter Your Search

Tenders by Countries

Browse Popular Sectors

Projects by Regions

Funding Agency

Support

CONTACT DETAILS

Discover Tenders by Uniforms Sector

Filter Your Search

FREE Trial plan for all new users!